Vyant Bio Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Out of Business

  • Employees
  • 85

Employees

  • Latest Deal Type
  • Out of Business

Vyant Bio General Information

Description

Provider of biotechnology and drug discovery services intended to incorporate human biology, engineering and data science to improve drug delivery.

Contact Information

Formerly Known As
Cancer Genetics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2 Executive Campus, 2370 State Route 70 West
  • Suite 310
  • Cherry Hill, NJ 08002-4102
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 2 Executive Campus, 2370 State Route 70 West
  • Suite 310
  • Cherry Hill, NJ 08002-4102
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vyant Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 26-Dec-2023 Completed Out of Business
11. PIPE 28-Mar-2022 Completed Generating Revenue
10. PIPE 01-Feb-2021 Completed Generating Revenue
9. Secondary Transaction - Open Market 21-Dec-2017 Completed Generating Revenue
8. PIPE 12-Dec-2017 Completed Generating Revenue
7. PIPE 09-Sep-2016 Completed Generating Revenue
6. 2PO 09-Nov-2015 Completed Generating Revenue
5. 2PO 14-Aug-2013 Completed Generating Revenue
4. IPO 05-Apr-2013 $6M $19.1M Completed Generating Revenue
3. Later Stage VC (Series B) 01-Nov-2010 $9.1M $13.1M Completed Generating Revenue
To view Vyant Bio’s complete valuation and funding history, request access »

Vyant Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A1
Series A 588,000 $0.000100 $8.46 $8.46 $8.46 3.19%
To view Vyant Bio’s complete cap table history, request access »

Vyant Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of biotechnology and drug discovery services intended to incorporate human biology, engineering and data scienc
Biotechnology
Cherry Hill, NJ
85 As of 2022

Plymouth Meeting, PA
 

Fremont, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vyant Bio Competitors (40)

One of Vyant Bio’s 40 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Personalis Formerly VC-backed Fremont, CA
Caris Life Sciences Formerly PE-Backed Irving, TX
Agenus Formerly VC-backed Lexington, MA
Dynavax Technologies Formerly VC-backed Emeryville, CA
You’re viewing 5 of 40 competitors. Get the full list »

Vyant Bio Patents

Vyant Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160130665-A1 Prognostic methods and systems for chronic lymphocytic leukemia Inactive 11-Nov-2014
CA-2901543-A1 Methods and tools for the diagnosis and prognosis of urogenital cancers Inactive 15-Feb-2013
EP-2956551-A1 Methods and tools for the diagnosis and prognosis of urogenital cancers Inactive 15-Feb-2013
US-20140235458-A1 Methods and tools for the diagnosis and prognosis of urogenital cancers Inactive 15-Feb-2013
US-20120202200-A1 Methods for detecting human papilloma virus-associated cancers Active 08-Sep-2010 C12Q1/708
To view Vyant Bio’s complete patent history, request access »

Vyant Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vyant Bio Acquisitions (5)

Vyant Bio’s most recent deal was a Merger/Acquisition with StemoniX for . The deal was made on 30-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
StemoniX 30-Mar-2021 Merger/Acquisition Biotechnology
VivoPharm 15-Aug-2017 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Response Genetics 09-Oct-2015 Merger/Acquisition Diagnostic Equipment
Gentris 16-Jul-2014 Merger/Acquisition Practice Management (Healthcare)
Cancer Genetics India 15-May-2014 Merger/Acquisition Laboratory Services (Healthcare)
To view Vyant Bio’s complete acquisitions history, request access »

Vyant Bio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Software & Services

Industry

Rank

Percentile

Internet Software and Services

Subindustry

Rank

Percentile

To view Vyant Bio’s complete esg history, request access »

Vyant Bio FAQs

  • When was Vyant Bio founded?

    Vyant Bio was founded in 1999.

  • Where is Vyant Bio headquartered?

    Vyant Bio is headquartered in Cherry Hill, NJ.

  • What is the size of Vyant Bio?

    Vyant Bio has 85 total employees.

  • What industry is Vyant Bio in?

    Vyant Bio’s primary industry is Biotechnology.

  • Is Vyant Bio a private or public company?

    Vyant Bio is a Private company.

  • What is Vyant Bio’s current revenue?

    The current revenue for Vyant Bio is .

  • How much funding has Vyant Bio raised over time?

    Vyant Bio has raised $83.1M.

  • Who are Vyant Bio’s competitors?

    Inovio Pharmaceuticals, Personalis, Caris Life Sciences, Agenus, and Dynavax Technologies are some of the 40 competitors of Vyant Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »